Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a wearable glucose sensor reliably monitor ICU patients?

NCT ID NCT07611721

First seen May 30, 2026 · Last updated Jun 18, 2026 · Updated 3 times

Summary

This study checks how accurate the Dexcom G7 continuous glucose monitor is for ICU patients after major abdominal surgery or organ transplant. About 62 adults will wear two sensors on their chest for up to 10 days. One sensor is used by doctors to adjust insulin, while the other is hidden for comparison. The goal is to see if the device can reliably track blood sugar levels in critically ill patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTENSIVE CARE (ICU) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Clinical and Experimental Medice

    RECRUITING

    Prague, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

congenital primary megaureter diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.